Senthil Vel Sundaram
Chief Financial Officer, Nightstar Therapeutics plc.
Companies
- Terns Pharmaceuticals, Inc.Board member Feb 4, 2021 to Jun 2, 20231
- Terns Pharmaceuticals, Inc.Chief executive officer Feb 4, 2021 to Jun 2, 20231
- Akili, Inc.Board member Sep 24, 2021 to Sep 24, 20212
- Sio Gene Therapies Inc.Board member Jul 1, 2019 to Apr 19, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Terns Pharmaceuticals, Inc.9,770 shares4May 31, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- May 31, 2023Bought 2,111 shares at $1.41 of Terns Pharmaceuticals, Inc.4
- Nov 30, 2022Bought 3 shares at $1.41 of Terns Pharmaceuticals, Inc.5
- May 31, 2022Bought 7,656 shares at $1.47 of Terns Pharmaceuticals, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAkili, Inc., Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Feb 3, 2023
- 6SEC EDGARForm 4 filed Jun 8, 2022